Potential explanations could include: correlation of Rb expression to cell cycle progression (i.e., quiescent tumors may not express detectable quantities of Rb protein), Rb loss or expression present only among tumor subclones possibly geographically missed by the biopsy needle track, or some RB1 gene variants that may not have eliminated the IHC epitope. This evidence concerns the gene RB1 and neoplasm.